1
|
Ou X, Wang J, Zhou R, Zhu S, Pang F, Zhou Y, Tian R, Ma X. Ability of 18F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma. CONTRAST MEDIA & MOLECULAR IMAGING 2019; 2019:4507694. [PMID: 30930700 PMCID: PMC6410462 DOI: 10.1155/2019/4507694] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/09/2018] [Accepted: 12/05/2018] [Indexed: 02/07/2023]
Abstract
Purpose. To investigate the value of SUV metrics and radiomic features based on the ability of 18F-FDG PET/CT in differentiating between breast lymphoma and breast carcinoma. Methods. A total of 67 breast nodules from 44 patients who underwent 18F-FDG PET/CT pretreatment were retrospectively analyzed. Radiomic parameters and SUV metrics were extracted using the LIFEx package on PET and CT images. All texture parameters were divided into six groups: histogram (HISTO), SHAPE, gray-level co-occurrence matrix (GLCM), gray-level run-length matrix (GLRLM), neighborhood gray-level different matrix (NGLDM), and gray-level zone-length matrix (GLZLM). Receiver operating characteristics (ROC) curves were generated to evaluate the discriminative ability of each parameter, and the optimal parameter in each group was selected to generate a new predictive variable by using binary logistic regression. PET predictive variable, CT predictive variable, the combination of PET and CT predictive variables, and SUVmax were compared in terms of areas under the curve (AUCs), sensitivity, specificity, and accuracy. Results. Except for SUVmin (p=0.971), the averages of FDG uptake metrics of lymphoma were significantly higher than those of carcinoma (p ≤ 0.001), with the following median values: SUVmean, 4.75 versus 2.38 g/ml (P < 0.001); SUVstd, 2.04 versus 0.88 g/ml (P=0.001); SUVmax, 10.69 versus 4.76 g/ml (P=0.001); SUVpeak, 9.15 versus 2.78 g/ml (P < 0.001); TLG, 42.24 versus 9.90 (P < 0.001). In the ROC curves analysis based on radiomic features and SUVmax, the AUC for SUVmax was 0.747, for CT texture parameters was 0.729, for PET texture parameters was 0.751, and for the combination of CT and PET texture parameters was 0.771. Conclusion. The SUV metrics in 18FDG PET/CT images showed a potential ability in the differentiation between breast lymphoma and carcinoma. The combination of SUVmax and PET/CT texture analysis may be promising to provide an effectively discriminant modality for the differential diagnosis of breast lymphoma and carcinoma, even for the differentiation of subtypes of lymphoma.
Collapse
Affiliation(s)
- Xuejin Ou
- West China School of Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China
- State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China
| | - Jian Wang
- School of Computer Science, Nanjing University of Science and Technology, No. 200, Xiaolinwei Road, Nanjing 210094, China
| | - Ruofan Zhou
- West China School of Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China
| | - Sha Zhu
- West China School of Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China
| | - Fuwen Pang
- Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China
| | - Yi Zhou
- Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China
| | - Rong Tian
- Department of Nuclear Medicine, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China
| | - Xuelei Ma
- Department of Biotherapy, West China Hospital and State Key Laboratory of Biotherapy, Sichuan University, Chengdu 610041, China
| |
Collapse
|
2
|
Al Battah AH, Al Kuwari EA, Hascsi Z, Nashwan AJ, Elomari H, Elsabah H, Al Azawi S, Kohla S, Soliman D, Yassin MA. Diffuse Large B-Cell Breast Lymphoma: A Case Series. Clin Med Insights Blood Disord 2017; 10:1179545X17725034. [PMID: 28839450 PMCID: PMC5560510 DOI: 10.1177/1179545x17725034] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2017] [Accepted: 07/11/2017] [Indexed: 01/24/2023]
Abstract
Primary breast lymphoma (PBL) is a rare disease, and few clinicohistopathologic features of the disease have been discussed in previous studies. It represents 2.2% of extranodal lymphomas and constitutes 0.04% to 0.5% of malignant breast neoplasms, despite the clinical and radiographic similarities between breast lymphoma and carcinoma, the prognosis, as reported in the literature, varies. No consensus exists on the best way to treat PBL. However, radiotherapy and chemotherapy were used alone or in combination to treat various cases of PBL. We retrospectively studied 3 cases of PBL of the breast seen in patients attending a tertiary cancer center in Qatar, between 2012 and 2015, in an attempt to determine the common clinical features, therapy, and prognosis of PBL.
Collapse
Affiliation(s)
- Afaf H Al Battah
- Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
| | | | - Zsolt Hascsi
- Radiology Department, Hamad Medical Corporation (HMC), Doha, Qatar
| | - Abdulqadir J Nashwan
- Nursing Department, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
| | - Halima Elomari
- Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
| | - Hisham Elsabah
- Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
| | - Safa Al Azawi
- Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
| | - Samah Kohla
- Department of Laboratory Medicine and Pathology, National Centre for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
| | - Dina Soliman
- Department of Laboratory Medicine and Pathology, National Centre for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar.,National Cancer Institute, Cairo, Egypt
| | - Mohamed A Yassin
- Division of Hematology, Department of Medical Oncology, National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC), Doha, Qatar
| |
Collapse
|
3
|
Bertaud S, Dindyal S, Kaur C, Vaidya J. Diffuse primary large B cell lymphoma of leg type presenting on the breast: a rare case of surgical excision. BMJ Case Rep 2011; 2011:bcr.05.2011.4286. [PMID: 22669883 DOI: 10.1136/bcr.05.2011.4286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Primary breast lymphoma is a rare subtype of breast malignancy whose diagnosis relies on histopathological characteristics and a high index of suspicion in clinically unusual presentations of breast pathology. The authors report a rare case of diffuse primary large B cell lymphoma of leg type presenting as a single lesion confined to the breast. Unusually for this subtype of lymphoma, the lesion was surgically excised and the patient, to date, has made an uneventful recovery.
Collapse
Affiliation(s)
- Sophie Bertaud
- Urology Department, Barnet and Chase Farm Hospital, Enfield, Middlesex, UK.
| | | | | | | |
Collapse
|
4
|
Adrada BE, Carkaci S, Whitman GJ. Case of the season: Large B-cell lymphoma involving both breasts. Semin Roentgenol 2011; 46:242-4. [PMID: 22035665 DOI: 10.1053/j.ro.2011.03.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Beatriz E Adrada
- Department of Diagnostic Radiology, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1439, USA
| | | | | |
Collapse
|
5
|
Iwatani T, Kawabata H, Miura D, Ota Y, Ohashi K. Complete Spontaneous Regression of Primary Diffuse Large B-Cell Lymphoma of the Breast. J Clin Oncol 2011; 29:e113-5. [DOI: 10.1200/jco.2010.31.2801] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6
|
Trabelsi A, Rammeh S, Gharbi O, Ben Yacoub L, Boujelbene N, Stita W, Korbi S. Lymphome non hodgkinien primitif du sein. IMAGERIE DE LA FEMME 2008. [DOI: 10.1016/s1776-9817(08)71714-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|